Related references
Note: Only part of the references are listed.International peripheral T-cell and natural killer/T-cell lymphoma study: Pathology findings and clinical outcomes
Julie M. Vose et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The relationship of FOXP3 expression and clinicopathological characteristics in adult T-cell leukemia/lymphoma
Kennosuke Karube et al.
MODERN PATHOLOGY (2008)
VCAP-AMP-VECP compared with biweekly CHOP for adult T-Cell leukemia-lymphoma: Japan clinical oncology group study JCOG9801
Kunihiro Tsukasaki et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Impact of visceral involvements and blood cell count abnormalities on survival in adult T-cell leukemia/lymphoma (ATLL)
Yumi Takasaki et al.
LEUKEMIA RESEARCH (2007)
Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia/lymphoma
Aya Oshiro et al.
BLOOD (2006)
Natural history of adult T-cell leukemia/lymphoma and approaches to therapy
GP Taylor et al.
ONCOGENE (2005)
Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma
T Fukushima et al.
LEUKEMIA (2005)
Expression of FoxP3, a key molecule in CD4+CD25+ regulatory T cells, in adult T-cell leukaemia/lymphoma cells
K Karube et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation
A Utsunomiya et al.
BONE MARROW TRANSPLANTATION (2001)
Share Paper
